Endometrial mixed Müllerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review.
Eur J Obstet Gynecol Reprod Biol
; 101(2): 204-8, 2002 Mar 10.
Article
em En
| MEDLINE
| ID: mdl-11858901
ABSTRACT
CASE A 67-year-old multiparous woman received 20mg tamoxifen daily for four years after surgical treatment of breast cancer. She presented with vaginal bleeding. Uterine curettage revealed a uterine MMT with heterologous elements. She was treated surgically with adjuvant radiotherapy. Tumor cells were found to be estrogen receptor negative and progesterone receptor positive. Uterine MMT may be linked to long term use of tamoxifen. A mechanism in developing MMT other than estrogen receptor pathway may be possible.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tamoxifeno
/
Neoplasias da Mama
/
Neoplasias do Endométrio
/
Tumor Mulleriano Misto
/
Antineoplásicos Hormonais
Tipo de estudo:
Etiology_studies
/
Systematic_reviews
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2002
Tipo de documento:
Article